# Stress Shortened Astrocyte Cilia in Mice

> A Nature study links stress to shorter signalling cilia on amygdala astrocytes and shows pathway-based behavioural improvement in mice, not a treatment for human anxiety.

_Source: Nature research article, cross-checked against PubMed, Crossref and OpenAlex; causal interventions and behavioural outcomes are from mice · 2026-08-14 · 7 min read · Verified against primary sources_

Canonical: https://iyu.app/e/amygdala-astrocyte-cilia-stress-mice

## The 60-second version

Stress shortened primary cilia on amygdala astrocytes, and restoring related signalling improved some behavioural measures in mice.

**Key points**

- Three mouse stress models linked astrocyte molecular changes to shorter primary cilia in the amygdala.
- Engineered Gi signalling and native S1PR1 targeting restored cilium length and selected behavioural outcomes.
- Ponesimod did not normalize all stress physiology or all behavioural measures.
- Human data showed expression and disease-associated gene patterns, not treatment efficacy.

**Verdict.** A detailed mouse mechanism and a plausible research target, but no evidence yet for treating human anxiety by targeting astrocyte cilia or repurposing ponesimod.

## Full explainer

> **⚑ Caveat:** The causal interventions and behavioural results were in mice. The study did not test ponesimod or any cilia-targeted treatment in people with anxiety, depression or stress-related disorders.


### Bottom line — What the study established

In several mouse stress models, astrocytes in the amygdala showed altered cilia-related genes and proteins, while their primary cilia became shorter. Activating astrocyte signalling restored cilium length and accompanied improvement on some behavioural tests.

- **Mice** — species used for causal tests
- **3** — stress models examined
- **0** — human treatment participants

Primary cilia are small membrane projections that organize cellular signals. The change was specific enough to be informative: cilia shortened on amygdala astrocytes, but not on nearby neurons or cortical astrocytes in the reported comparisons.


### Design — How the mouse evidence was built

- **Stress models:** Fourteen days of chronic restraint or water avoidance, plus a separate spared-nerve-injury model of pain-related stress.
- **Main stress cohorts:** About 18–20 unstressed mice and 10 mice in each restraint or water-avoidance group for key physiological measures; individual experiments used different cohorts.
- **Cell measurements:** Astrocyte-selective RNA sequencing, near-membrane proteomics and microscopy of cilium markers.
- **Causal tests:** Engineered Gi signalling, native S1PR1 targeting and selective genetic disruption of astrocyte cilia.
- **Human component:** Postmortem tissue and reanalysis of existing single-nucleus gene-expression datasets, not a clinical intervention.

After chronic restraint or water avoidance, roughly 80% of amygdala astrocytes still carried detectable cilia, but the cilia were shorter and smaller. Stress also shifted dozens of astrocyte genes, with cilia-related pathways prominent among the downregulated signals.


### Intervention — What improved and what did not

Astrocyte-specific activation of an engineered Gi receptor restored cilium length and improved selected stress-related readouts. The team then used ponesimod to activate native S1PR1 signalling. In groups of 10 mice, sucrose-preference and forced-swim outcomes moved toward unstressed controls; imaging in 4 mice per group showed restored cilium length.

> **i** The response was incomplete. Ponesimod did not normalize body weight, adrenal or thymus changes, corticosterone, or the reported open-field deficits. S1PR1 was found on the astrocyte plasma membrane, not in the cilium itself.

> Better scores on selected mouse tests are not the same as treating human anxiety.


### Human evidence — Expression is not clinical efficacy

Cilia-related genes were widely expressed in human amygdala astrocytes. S1PR1 was detected in about half of ALDH1L1-positive astrocytes across four neurotypical donors, and psychiatric datasets contained altered cilia-related gene patterns. These observations connect the mechanism to human biology, but they do not show cilium shortening after human stress or symptom improvement after pathway targeting.


### Limits — Reasons for caution

- Mouse open-field, sucrose-preference and forced-swim tests are behavioural proxies, not diagnoses of anxiety or depression.
- Some imaging and molecular comparisons used four mice per group, even when many cells were measured.
- Mice were randomized, but the authors report that blinding was not always feasible; automated scoring reduced some subjectivity.
- The paper does not define a clinically meaningful cilium-length threshold.
- Human analyses were postmortem and observational, so they cannot establish treatment causality.

> **i** Ono Pharmaceutical funded part of the study. One co-first author is an Ono employee, and the ponesimod behavioural experiments were performed at Ono. The other authors declared no competing interests.


### Practical meaning — What to do now

Do not start, stop or repurpose ponesimod on the basis of this study. The next useful evidence is independent replication, direct measurement in human-relevant systems and clinical research that separates biomarker change from meaningful symptom benefit and safety.


## Primary sources

- [Telegram source post](https://t.me/CNSmydream/1412)
- [Nature paper (DOI)](https://doi.org/10.1038/s41586-026-10874-0)
- [PubMed record](https://pubmed.ncbi.nlm.nih.gov/42557328/)
- [Crossref metadata](https://api.crossref.org/works/10.1038/s41586-026-10874-0)
- [OpenAlex record](https://openalex.org/W7172540636)

---
_Published by iyu (https://iyu.app) — the day's AI news, checked against primary sources and rewritten in plain language. Free to quote with attribution and a link to the canonical URL._